Skip to content
PICO Portalanswers from OpenAlex

Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies

PaperCitations, authors & open-access status

Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies is a paper indexed in PICO Portal from OpenAlex.

How many citations does Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies have?

PICO Portalcitation count

Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies has 52 citations in the OpenAlex counts PICO Portal stores.

When was Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies published?

PICO Portalyear

Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies has 2014 year in the PICO Portal index.

What is the open-access status of Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies?

PICO Portaloa status

Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies has closed oa status in the PICO Portal index.

What is the DOI of Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies?

PICO Portaldoi

The DOI for Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies is on the source record.

What is the PMID of Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies?

PICO Portalpmid

The PMID for Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies is on the source record.

What is the OpenAlex record for Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies?

PICO Portalopenalex

The OpenAlex for Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial